HCPCS J7644: Ipratropium Bromide Inhalation Solution, Unit-Dose via DME

HCPCS Level II code J7644 denotes ipratropium bromide inhalation solution, an FDA-approved, non-compounded unit-dose product billed per milligram when delivered through durable medical equipment. Nationally, this code matters for reimbursement of respiratory medication delivered via nebulizers and other DME in outpatient, home health, and ambulatory respiratory care settings. Proper coding ensures consistent coverage determinations and accurate claims for inhaled anticholinergic therapy used in obstructive airway disease management.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for ipratropium inhalation solution and how J7644 maps to service delivery through DME. The publication summarizes payment benchmarks and common billing practices, highlights relevant policy considerations that affect coverage and billing workflows, and points to areas where coding clarity influences claims adjudication. Data not available in the input is noted where applicable.

This summary is intended for billing managers, revenue cycle staff, and clinicians involved in respiratory therapy billing who need a clear national perspective on coding and policy implications for inhalation medications administered via DME.

Billing Code Overview

HCPCS Level II code J7644 describes ipratropium bromide inhalation solution, an FDA-approved, non-compounded final product supplied in unit-dose form and measured per milligram. The code applies when the medication is administered through durable medical equipment (DME), reflecting single-dose liquid preparations intended for inhalation therapy.

Service Type: Medication administration via DME (inhalation solution, unit dose)

Typical Site of Service: Durable medical equipment settings and outpatient infusion/respiratory therapy sites, including home use with DME and ambulatory respiratory care locations.

Clinical Context

A typical patient is an adult or pediatric patient with obstructive airway disease (for example, chronic obstructive pulmonary disease or acute exacerbation of chronic bronchitis) who requires inhaled anticholinergic bronchodilator therapy. The medication J7644 (ipratropium bromide, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose form, per milligram) is supplied in unit-dose ampules or vials and delivered via a nebulizer provided as durable medical equipment. Clinical workflow: patient evaluated in outpatient pulmonary clinic, emergency department, or home health setting; clinician documents diagnosis, orders ipratropium solution and nebulizer DME; pharmacy dispenses unit-dose medication labeled per milligram; medication is administered by respiratory therapist, nurse, or patient/caregiver using the DME nebulizer; administration, drug amount (mg), lot number, and route (inhalation via nebulizer) are documented in the medical record; relevant supplies and DME are billed separately as applicable. Typical site of service: outpatient clinic, emergency department, observation unit, or home health/hospice with DME support.

Coding Specifications

Modifier	Description	When to Use
`JW`	Drug amount discarded/not administered	Use when part of the dispensed ipratropium solution is discarded and must be reported for wastage tracking and payer requirements.

Taxonomy Code	Specialty	Notes
`207RP0000X`	Pulmonary Disease	Pulmonologists prescribe inhaled bronchodilators and direct nebulized therapy.
`207L00000X`	Allergy & Immunology	Allergists manage obstructive airway disease and may prescribe inhaled therapies.
`251B00000X`	Respiratory Therapy	Respiratory therapists perform nebulized drug administration and DME training.
`207Q00000X`	Critical Care Medicine	Critical care clinicians manage acute respiratory exacerbations requiring nebulized bronchodilators.
`363LA2200X`	Home Health Agency	Home health clinicians coordinate DME use and home administration of unit-dose inhalation solutions.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	Common indication for nebulized ipratropium to relieve bronchospasm during exacerbations.
`J45.901`	Unspecified asthma, uncomplicated	Asthma patients may receive ipratropium for bronchodilator therapy when indicated, often in combination with beta-agonists.
`J20.9`	Acute bronchitis, unspecified	Nebulized anticholinergic therapy can be used adjunctively for bronchospasm in acute bronchitis.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Nebulized bronchodilators including ipratropium may be used as part of supportive therapy in respiratory failure with obstructive component.
`R06.2`	Wheezing	Symptom code indicating bronchospasm where inhaled ipratropium may be administered for bronchodilation.
`J42`	Unspecified chronic bronchitis	Chronic bronchitis with airflow obstruction may be managed with inhaled anticholinergics including ipratropium.
`Z79.899`	Other long term (current) drug therapy	Used to indicate ongoing inhaled therapy regimens when documenting chronic medication use.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`94640`	Airway resistance testing; spirometry, including maximal voluntary ventilation, when performed	May be performed before or after therapy to assess bronchospasm and response to ipratropium inhalation.
`94664`	Demonstration and/or evaluation of patient utilization of an aerosol generator, nebulizer, metered dose inhaler or IPPB device	Performed when teaching patient or caregiver correct nebulizer technique for administration of unit-dose ipratropium solution.
`94620`	Pulmonary stress testing; spirometry, including bronchodilator administration and spirometry post-bronchodilator	Used when bronchodilator responsiveness testing includes administration of inhaled ipratropium as the bronchodilator agent.
`99152`	Moderate sedation services provided by same physician performing a pain management or procedure (typically not directly related)	Not commonly used for routine nebulized ipratropium; listed when procedural sedation coincides with airway procedures where inhaled bronchodilator is also given.
`J7644`	Ipratropium bromide, inhalation solution, unit dose, per mg (HCPCS Level II)	HCPCS code for the medication itself; billed for the unit-dose inhalation solution administered via DME nebulizer.

OpenPayer

Summary & Overview